BioSpace News Archive

Xtant plans to hold a Special Meeting of Stockholders to vote on matters required to be approved by stockholders in connection with the transactions contemplated by the Restructuring Agreement.

The milestone will be paid pursuant to an acquisition agreement for TRISENOX previously entered into with Teva under which CTI BioPharma is eligible to receive up to an additional $50M in payments upon achievement by Teva of specified sales and development milestones related to TRISENOX.

Alligator Bioscience announced today the appointment of Anu Balendran, PhD, as VP Business Development.

Martin Koch comes to Inotrem with more than 25 years of experience in the healthcare industry.

ERS Genomics announced that yesterday, the European Patent Office revoked in its entirety the first of several Broad Institute patents that are facing opposition there.

Enrollment of subjects has started for the IND opening study, which will test single and multiple doses of a solid-dose formulation of BHV-5000 in healthy volunteers.

Dr van Alphen has over 20 years of experience in clinical development and medical affairs, employed in roles of increasing responsibility.

A conference call is planned for Thursday, February 1, at 15:00 CET / 9:00 EST hosted by Peer M. Schatz, CEO, and Roland Sackers, CFO.

Advion, a leading systems and consumables developer for the life sciences industry, announced that, during the year ending December 31, 2017, it had reached several major milestones.

To help patients by addressing the often unwarranted shortages and high costs of lifesaving generic medications, Intermountain Healthcare is leading a collaboration with Ascension, SSM Health and Trinity Health, in consultation with the U.S. Department of Veterans Affairs* (VA), to form a new, not-for-profit generic drug company.